Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/26/1999WO1999042446A1 Cyclic amide compounds
08/26/1999WO1999042445A1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
08/26/1999WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments
08/26/1999WO1999042443A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
08/26/1999WO1999042441A1 Anti-retroviral functionalised aromatic compounds
08/26/1999WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
08/26/1999WO1999042429A1 Antitumor agents
08/26/1999WO1999042427A1 E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof
08/26/1999WO1999042146A1 Products comprising fibrinogen for use in therapy
08/26/1999WO1999042136A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
08/26/1999WO1999042134A2 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders
08/26/1999WO1999042128A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999WO1999042116A1 Novel disulfides and thiol compounds
08/26/1999WO1999042113A1 Composition and method for the treatment of bladder cancer
08/26/1999WO1999042111A1 High-energy cyclodextrin complexes
08/26/1999WO1999042110A1 Regulation of estrus and ovulation in gilts
08/26/1999WO1999042109A1 Combination preparation of estrogen and anti-estrogen
08/26/1999WO1999042108A1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system
08/26/1999WO1999042107A1 Piperazine derivatives for treating bone deficit conditions
08/26/1999WO1999042106A1 Anti-hcmv agent
08/26/1999WO1999042105A1 Epimorphian compound and its use
08/26/1999WO1999042104A1 Use of macrolide compounds for treating glaucoma
08/26/1999WO1999042103A1 Use of a glutamate release inhibitor in the treatment of retinal ischemia
08/26/1999WO1999042102A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
08/26/1999WO1999042101A1 Dietary control of arachidonic acid metabolism
08/26/1999WO1999042099A1 Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
08/26/1999WO1999042098A1 Small molecules that increase the conversion of food to body weight gain
08/26/1999WO1999042097A1 Small molecules that elicit a polarized th1 response and for modulation of cellular immunity
08/26/1999WO1999042096A1 Composition comprising theanine
08/26/1999WO1999042095A1 Pharmaceutical combinations containing tramadol
08/26/1999WO1999042094A1 Use of curcumin in treatment of psoriasis, inflammation, skin wounds, burns, and eczemas
08/26/1999WO1999042093A2 Antagonists of a2b human adenosine receptors
08/26/1999WO1999042092A2 Compounds and methods of use for treatment of neurogenic inflammation
08/26/1999WO1999042091A2 Use of polycations as endosomolytic agents
08/26/1999WO1999042090A2 Treating cancer
08/26/1999WO1999042089A2 Use of thiadiazolo[4,3-a]pyridine derivatives
08/26/1999WO1999042088A2 Method for the treatment of diseases or disorders of the inner ear
08/26/1999WO1999042086A1 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent
08/26/1999WO1999042083A1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
08/26/1999WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999WO1999042001A1 Calorically dense nutritional composition
08/26/1999WO1999041984A1 INTERACTION BETWEEN THE MEC1-DEPENDENT DNA SYNTHESIS CHECKPOINT AND G1 CYCLIN FUNCTION IN $i(SACCAROMYCES CEREVISIAE)
08/26/1999WO1999033825A8 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositons containing them
08/26/1999WO1999032606A3 Neural precursor cells, method for the production and use thereof in neural defect therapy
08/26/1999WO1999031060A3 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants
08/26/1999WO1999030697A3 Combination effective for the treatment of impotence
08/26/1999WO1999029700A3 Cyclohexadiene-derivatives as pesticides
08/26/1999WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/26/1999WO1999026909A3 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
08/26/1999WO1999026609A3 Therapeutic treatment for chronic myeloid leukemia and acute lymphoid leukemia
08/26/1999WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/26/1999WO1999024421A8 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/26/1999WO1999022720A3 Selective cyclooxygenase-2 inhibitors against premature labor
08/26/1999WO1999021501A9 Spine distraction implant
08/26/1999WO1999018973A3 Liquid presentations of oxazaphosphorine-containing pharmaceutical products
08/26/1999WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
08/26/1999WO1999006428A9 Tango-72 and tango-77 nucleic acid molecules and polypeptides
08/26/1999DE19907493A1 Recombinant nucleic acid encoding modified forms of peptides involved in neurodegenerative diseases, useful for identifying potential therapeutic agents
08/26/1999DE19824653A1 Use of compounds concentrating in necrotic tissue as drug depots, e.g. for radiation therapy, pharmacotherapy, restenosis prevention and diagnosis
08/26/1999DE19808634A1 Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties
08/26/1999DE19807979A1 New water-soluble dendrimeric fullerene derivatives, useful as neuroprotective and radical scavenging drugs
08/26/1999DE19807791A1 Combination preparation of estrogen with 7-aminoalkyl-estratriene antiestrogen, useful in hormone replacement therapy, e.g. for treatment osteoporosis, Alzheimer's disease and hot flushes
08/26/1999DE19807774A1 Use of flavone, flavanone or flavonoid compound for protection of ascorbic acid or ascorbyl compound against oxidation, especially in cosmetic and dermatological preparations,
08/26/1999DE19807659A1 Composition for disaggregating blood platelets to lower blood viscosity and improve blood flow
08/26/1999DE19807535A1 Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
08/26/1999DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction
08/26/1999DE19807265A1 New adenoviral vector useful for gene therapy
08/26/1999CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999CA2321961A1 Novel disulfides and thiol compounds
08/26/1999CA2321814A1 Small molecules that increase the conversion of food to body weight gain
08/26/1999CA2321498A1 Pharmaceutical preparations for the selectively supplementing oestrogen deficiency in the central nervous system
08/26/1999CA2321482A1 Treating cancer
08/26/1999CA2321481A1 Treating cancer
08/26/1999CA2321480A1 Treating cancer
08/26/1999CA2321479A1 Treating cancer
08/26/1999CA2321467A1 Treating cancer
08/26/1999CA2321458A1 Treating cancer
08/26/1999CA2321438A1 Treating cancer
08/26/1999CA2321427A1 Combination preparation of estrogen and anti-estrogen
08/26/1999CA2321296A1 Composition and method for the treatment of bladder cancer
08/26/1999CA2321278A1 Novel compounds
08/26/1999CA2321222A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999CA2321219A1 Anti-retroviral functionalised aromatic compounds
08/26/1999CA2321182A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists
08/26/1999CA2321102A1 Regulation of estrus and ovulation in gilts
08/26/1999CA2321052A1 Process for the obtaining of hmg-coa reductase inhibitors of high purity
08/26/1999CA2320990A1 Method for the production of polymers from n-vinyl compounds
08/26/1999CA2320971A1 Cyclic amide compounds
08/26/1999CA2320808A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999CA2320772A1 High-energy cyclodextrin complexes
08/26/1999CA2320743A1 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent
08/26/1999CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
08/26/1999CA2320354A1 Novel compounds and their use as positive ampa receptor modulators
08/26/1999CA2320219A1 Products comprising fibrinogen for use in therapy
08/26/1999CA2318959A1 Epimorphian compound and its use
08/26/1999CA2318836A1 Histamine h3 receptor ligands
08/26/1999CA2318818A1 Fermentative preparation process for cytostatics and crystal forms thereof
08/26/1999CA2318237A1 Use of thiadiazolo[4,3-a]pyridine derivatives
08/26/1999CA2309943A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
08/26/1999CA2288178A1 Piperazine derivatives for treating bone deficit conditions
1 ... 6454 6455 6456 6457 6458 6459 6460 6461 6462 6463 6464 6465 6466 6467 6468 6469 6470 6471 6472 6473 6474 ... 7860